Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients ------ Risk Early Warning and Follow-up Study

NCT07147335 is registered in ClinicalTrials.gov with The First Affiliated Hospital of University of South China as lead sponsor.

NCT NCT07147335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07147335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients ------ Risk Early Warning and Follow-up Study
Lead sponsor
The First Affiliated Hospital of University of South China
Phase
Observational
Overall status
Recruiting
Start date
May 16, 2025
Completion date
March 31, 2028
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, hepotacellular carcinoma